VERWENDUNG VON 4,17-BETA-DIHYDROXYANDROST-4-EN-3- ON ZUR BEHANDLUNG VON KREBS

摘要

The present invention relates to novel uses of 4,17²-dihydroxyandrost-4-ene-3-one (hereinafter 4-hydroxytestosterone), to a process for their preparation, to pharmaceutical compositions containing them, and to the use of said compounds for the prophylaxis and/or treatment of hormone-dependent or hormone receptor regulated cancers in mammals.